These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7827760)

  • 61. Alpha 1-antitrypsin augmentation therapy.
    Sandhaus RA
    Agents Actions Suppl; 1993; 42():97-102. PubMed ID: 8356934
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.
    Brantly ML; Paul LD; Miller BH; Falk RT; Wu M; Crystal RG
    Am Rev Respir Dis; 1988 Aug; 138(2):327-36. PubMed ID: 3264124
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
    Stockley RA; Edgar RG; Pillai A; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study.
    Sorroche PB; Fernández Acquier M; López Jove O; Giugno E; Pace S; Livellara B; Legal S; Oyhamburu J; Saez MS
    Arch Bronconeumol; 2015 Nov; 51(11):539-43. PubMed ID: 25800328
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The discovery of α1-antitrypsin and its role in health and disease.
    Janciauskiene SM; Bals R; Koczulla R; Vogelmeier C; Köhnlein T; Welte T
    Respir Med; 2011 Aug; 105(8):1129-39. PubMed ID: 21367592
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Criteria for alpha 1-antitrypsin substitution.
    Viskum K; Kok-Jensen A
    Lung; 1990; 168 Suppl():586-91. PubMed ID: 2117167
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relation of functional characteristics and serum alpha-1-antitrypsin (AAT) concentration in patients with PiMM phenotype and chronic obstructive pulmonary disease (COPD).
    Zarić B; Stojčević J; Andrijević L; Andrijević I; Kuruc V; Veselinović I; Salatić I
    Eur J Intern Med; 2011 Dec; 22(6):603-6. PubMed ID: 22075288
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Obstructive pulmonary syndromes in children with alpha 1 antitrypsin deficiency. 3 cases].
    Gerbeaux J; Grimfeld A; Gaultier C; Baculard A; Mensch B; Tournier G
    Nouv Presse Med; 1975 Dec; 4(43):3045-50. PubMed ID: 1083504
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Alpha-1 antitrypsin deficiency. The experience of Pulido Valente Hospital with augmentation therapy].
    Alves Costa C; Santos C
    Rev Port Pneumol; 2009; 15(3):473-82. PubMed ID: 19401796
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
    Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
    COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.
    Greulich T; Vogelmeier CF
    Ther Adv Respir Dis; 2016 Feb; 10(1):72-84. PubMed ID: 26341117
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chronic obstructive pulmonary disease, with and without alpha-1-antitrypsin deficiency: management practices in the U.K.
    Hill AT; Campbell EJ; Ward AM; Stockley RA
    Respir Med; 1999 Jul; 93(7):481-90. PubMed ID: 10464835
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Emphysema of early onset associated with a complete deficiency of alpha-1-antitrypsin (null homozygotes).
    Cox DW; Levison H
    Am Rev Respir Dis; 1988 Feb; 137(2):371-5. PubMed ID: 3257661
    [TBL] [Abstract][Full Text] [Related]  

  • 74. One- to four-year follow-up of endobronchial lung volume reduction in alpha-1-antitrypsin deficiency patients: a case series.
    Hillerdal G; Mindus S
    Respiration; 2014; 88(4):320-8. PubMed ID: 25227936
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
    Zuo L; Pannell BK; Zhou T; Chuang CC
    Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
    Louie SG; Sclar DA; Gill MA
    Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
    van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
    Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Alpha 1-antitrypsin deficiency--diagnosis, treatment, and control: identification of patients.
    Buist AS
    Lung; 1990; 168 Suppl():543-51. PubMed ID: 2117163
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).
    Lior Y; Geyra A; Lewis EC
    Expert Opin Ther Pat; 2016 May; 26(5):581-9. PubMed ID: 26966859
    [TBL] [Abstract][Full Text] [Related]  

  • 80. From the NIH: Intravenous replacement therapy for patients with severe alpha 1-antitrypsin deficiency.
    JAMA; 1982 Oct; 248(14):1693. PubMed ID: 6981713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.